 Patrick Carry
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 11 | 2023 | 181 | 3.480 |
Why?
| | Acetabulum | 16 | 2023 | 102 | 1.750 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 47 | 1.680 |
Why?
| | DNA Methylation | 5 | 2021 | 498 | 1.510 |
Why?
| | Islets of Langerhans | 4 | 2023 | 729 | 1.320 |
Why?
| | Humeral Fractures | 8 | 2022 | 50 | 1.200 |
Why?
| | Spinal Fusion | 6 | 2022 | 216 | 1.200 |
Why?
| | Fractures, Bone | 8 | 2023 | 372 | 1.110 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 213 | 1.050 |
Why?
| | Autoimmunity | 6 | 2023 | 822 | 0.960 |
Why?
| | Hip Joint | 11 | 2022 | 131 | 0.950 |
Why?
| | Hip Dislocation | 8 | 2023 | 50 | 0.950 |
Why?
| | Adolescent | 58 | 2023 | 17889 | 0.930 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2023 | 3254 | 0.890 |
Why?
| | Propensity Score | 3 | 2023 | 225 | 0.860 |
Why?
| | Child | 59 | 2023 | 18488 | 0.830 |
Why?
| | Kyphosis | 1 | 2022 | 34 | 0.820 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 86 | 0.800 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 116 | 0.790 |
Why?
| | Osteotomy | 10 | 2017 | 152 | 0.790 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 10 | 0.770 |
Why?
| | Radiography | 21 | 2021 | 826 | 0.760 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.740 |
Why?
| | Genome-Wide Association Study | 3 | 2021 | 1217 | 0.740 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 210 | 0.720 |
Why?
| | Diseases in Twins | 1 | 2021 | 175 | 0.710 |
Why?
| | Postoperative Complications | 18 | 2020 | 2161 | 0.710 |
Why?
| | Semicircular Canals | 1 | 2020 | 28 | 0.690 |
Why?
| | Retrospective Studies | 52 | 2023 | 12608 | 0.680 |
Why?
| | Phospholipids | 1 | 2021 | 202 | 0.680 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 36 | 0.680 |
Why?
| | Ultrasonography | 6 | 2022 | 641 | 0.640 |
Why?
| | Surgeons | 1 | 2022 | 238 | 0.630 |
Why?
| | Upper Extremity | 2 | 2023 | 84 | 0.620 |
Why?
| | Humans | 100 | 2023 | 115587 | 0.620 |
Why?
| | Joint Instability | 6 | 2022 | 166 | 0.600 |
Why?
| | Health Status | 1 | 2023 | 728 | 0.600 |
Why?
| | Algorithms | 2 | 2023 | 1490 | 0.570 |
Why?
| | Fracture Fixation | 3 | 2015 | 78 | 0.570 |
Why?
| | Athletic Injuries | 6 | 2022 | 456 | 0.550 |
Why?
| | Femur | 5 | 2023 | 194 | 0.540 |
Why?
| | Female | 68 | 2023 | 59913 | 0.540 |
Why?
| | Arteries | 1 | 2018 | 250 | 0.530 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 56 | 0.530 |
Why?
| | Male | 68 | 2023 | 55949 | 0.520 |
Why?
| | Clavicle | 3 | 2014 | 31 | 0.510 |
Why?
| | Tibial Fractures | 3 | 2023 | 70 | 0.500 |
Why?
| | Pain, Postoperative | 5 | 2018 | 195 | 0.490 |
Why?
| | Child, Preschool | 18 | 2021 | 9133 | 0.480 |
Why?
| | Lower Extremity | 3 | 2023 | 337 | 0.470 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 131 | 0.460 |
Why?
| | Femur Head | 3 | 2021 | 35 | 0.450 |
Why?
| | Treatment Outcome | 31 | 2023 | 9159 | 0.450 |
Why?
| | Return to Sport | 5 | 2022 | 78 | 0.450 |
Why?
| | Oxylipins | 3 | 2023 | 27 | 0.420 |
Why?
| | Snow Sports | 1 | 2012 | 1 | 0.420 |
Why?
| | Head Protective Devices | 1 | 2012 | 15 | 0.410 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 9 | 0.410 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 196 | 0.390 |
Why?
| | Case-Control Studies | 8 | 2023 | 3022 | 0.390 |
Why?
| | Insulin | 2 | 2021 | 2082 | 0.380 |
Why?
| | Epiphyses | 7 | 2021 | 19 | 0.370 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 7 | 0.370 |
Why?
| | Pronation | 1 | 2010 | 10 | 0.360 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 9 | 0.360 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3069 | 0.350 |
Why?
| | Brain Concussion | 3 | 2022 | 469 | 0.350 |
Why?
| | Bone Nails | 4 | 2019 | 62 | 0.350 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 15 | 0.350 |
Why?
| | Parent-Child Relations | 1 | 2012 | 234 | 0.340 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2578 | 0.330 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 9 | 0.320 |
Why?
| | Casts, Surgical | 2 | 2019 | 31 | 0.290 |
Why?
| | Clubfoot | 2 | 2019 | 14 | 0.290 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 6 | 0.280 |
Why?
| | Disease Progression | 4 | 2022 | 2418 | 0.280 |
Why?
| | Sports | 2 | 2022 | 175 | 0.280 |
Why?
| | Prevalence | 4 | 2022 | 2264 | 0.280 |
Why?
| | Cohort Studies | 8 | 2021 | 4944 | 0.280 |
Why?
| | Spine | 2 | 2018 | 141 | 0.270 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 250 | 0.270 |
Why?
| | Cadaver | 3 | 2022 | 316 | 0.270 |
Why?
| | Risk Factors | 15 | 2023 | 8697 | 0.270 |
Why?
| | Clinical Protocols | 2 | 2018 | 234 | 0.270 |
Why?
| | Infant | 13 | 2023 | 7979 | 0.260 |
Why?
| | Athletes | 5 | 2022 | 323 | 0.260 |
Why?
| | Young Adult | 15 | 2022 | 10470 | 0.250 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 19 | 0.250 |
Why?
| | Tibia | 2 | 2023 | 172 | 0.240 |
Why?
| | Range of Motion, Articular | 7 | 2022 | 354 | 0.240 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 43 | 0.240 |
Why?
| | Biomechanical Phenomena | 6 | 2022 | 677 | 0.240 |
Why?
| | Elbow Joint | 3 | 2019 | 60 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2020 | 291 | 0.230 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 9 | 0.230 |
Why?
| | Time Factors | 13 | 2021 | 6165 | 0.230 |
Why?
| | Odds Ratio | 8 | 2019 | 962 | 0.230 |
Why?
| | Orthotic Devices | 3 | 2022 | 30 | 0.220 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 76 | 0.220 |
Why?
| | Reoperation | 6 | 2017 | 525 | 0.220 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 79 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2392 | 0.220 |
Why?
| | Growth Plate | 2 | 2023 | 33 | 0.210 |
Why?
| | Epigenesis, Genetic | 3 | 2021 | 526 | 0.210 |
Why?
| | Humerus | 2 | 2022 | 43 | 0.210 |
Why?
| | Meniere Disease | 1 | 2023 | 30 | 0.210 |
Why?
| | Adult | 18 | 2023 | 30718 | 0.210 |
Why?
| | Ligaments, Articular | 1 | 2022 | 56 | 0.200 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 38 | 0.200 |
Why?
| | Wrist Joint | 1 | 2022 | 59 | 0.200 |
Why?
| | Hip Fractures | 1 | 2023 | 75 | 0.200 |
Why?
| | Spinal Fractures | 1 | 2023 | 78 | 0.200 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 19 | 0.200 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 100 | 0.200 |
Why?
| | Migraine Disorders | 1 | 2023 | 83 | 0.200 |
Why?
| | Radius Fractures | 1 | 2022 | 56 | 0.200 |
Why?
| | Ankle Fractures | 1 | 2022 | 18 | 0.200 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 2 | 0.200 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.200 |
Why?
| | Bone Plates | 2 | 2022 | 78 | 0.200 |
Why?
| | Age Factors | 7 | 2021 | 2907 | 0.190 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 43 | 0.190 |
Why?
| | Selection Bias | 1 | 2021 | 33 | 0.190 |
Why?
| | Incidence | 8 | 2023 | 2335 | 0.190 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 5 | 0.190 |
Why?
| | Cerebral Palsy | 1 | 2022 | 78 | 0.190 |
Why?
| | Follow-Up Studies | 10 | 2021 | 4440 | 0.190 |
Why?
| | Neck Muscles | 1 | 2021 | 11 | 0.190 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 14 | 0.180 |
Why?
| | Pelvic Bones | 1 | 2023 | 128 | 0.180 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 217 | 0.180 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 39 | 0.180 |
Why?
| | Probability | 1 | 2021 | 294 | 0.180 |
Why?
| | Arthralgia | 2 | 2020 | 50 | 0.180 |
Why?
| | Muscle Strength | 2 | 2021 | 275 | 0.180 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1087 | 0.180 |
Why?
| | Suture Techniques | 2 | 2019 | 130 | 0.180 |
Why?
| | Bias | 1 | 2021 | 179 | 0.180 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 133 | 0.180 |
Why?
| | Intraoperative Complications | 1 | 2001 | 126 | 0.170 |
Why?
| | Patella | 1 | 2019 | 25 | 0.170 |
Why?
| | Play and Playthings | 1 | 2019 | 31 | 0.170 |
Why?
| | Recreation | 1 | 2019 | 23 | 0.170 |
Why?
| | Histology | 1 | 2019 | 3 | 0.170 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 11 | 0.160 |
Why?
| | Education, Professional | 1 | 2019 | 19 | 0.160 |
Why?
| | Health Occupations | 1 | 2019 | 30 | 0.160 |
Why?
| | Equipment Failure | 1 | 2019 | 109 | 0.160 |
Why?
| | Gene Frequency | 1 | 2020 | 485 | 0.160 |
Why?
| | Logistic Models | 5 | 2017 | 1856 | 0.160 |
Why?
| | Tendons | 1 | 2019 | 120 | 0.160 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 86 | 0.150 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 64 | 0.150 |
Why?
| | Interleukins | 1 | 2020 | 238 | 0.150 |
Why?
| | Anesthesia, Local | 1 | 2018 | 14 | 0.150 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 9 | 0.150 |
Why?
| | Genetic Association Studies | 1 | 2020 | 343 | 0.150 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 25 | 0.150 |
Why?
| | Femoral Nerve | 1 | 2018 | 15 | 0.150 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 313 | 0.150 |
Why?
| | Bone Malalignment | 1 | 2017 | 14 | 0.150 |
Why?
| | Arthroscopy | 2 | 2020 | 200 | 0.150 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 20 | 0.150 |
Why?
| | Autoantibodies | 2 | 2022 | 1360 | 0.150 |
Why?
| | Collagen | 1 | 2020 | 415 | 0.150 |
Why?
| | Meningomyelocele | 1 | 2018 | 57 | 0.150 |
Why?
| | Sciatic Nerve | 1 | 2018 | 56 | 0.150 |
Why?
| | Femoral Fractures | 1 | 2018 | 67 | 0.150 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 96 | 0.140 |
Why?
| | Nerve Block | 1 | 2018 | 62 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 385 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2022 | 731 | 0.140 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 29 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 495 | 0.140 |
Why?
| | Learning Curve | 1 | 2017 | 63 | 0.140 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 4 | 0.140 |
Why?
| | Prospective Studies | 7 | 2023 | 6264 | 0.140 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 24 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4435 | 0.140 |
Why?
| | Metabolomics | 1 | 2021 | 538 | 0.130 |
Why?
| | Pain | 1 | 2022 | 712 | 0.130 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 51 | 0.130 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 78 | 0.130 |
Why?
| | Electrocardiography | 2 | 2016 | 560 | 0.130 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1805 | 0.130 |
Why?
| | Radius | 1 | 2015 | 33 | 0.130 |
Why?
| | Caregivers | 1 | 2022 | 713 | 0.130 |
Why?
| | Shoulder Fractures | 1 | 2015 | 12 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2125 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 333 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1180 | 0.120 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 31 | 0.120 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 68 | 0.120 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 154 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 239 | 0.120 |
Why?
| | Diet | 1 | 2021 | 1072 | 0.120 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 35 | 0.120 |
Why?
| | Long QT Syndrome | 1 | 2015 | 59 | 0.120 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 43 | 0.120 |
Why?
| | Menisci, Tibial | 1 | 2014 | 53 | 0.120 |
Why?
| | Autografts | 1 | 2014 | 41 | 0.120 |
Why?
| | Obesity | 3 | 2015 | 2517 | 0.120 |
Why?
| | Patient Compliance | 1 | 2018 | 524 | 0.120 |
Why?
| | Bone Diseases | 1 | 2014 | 58 | 0.120 |
Why?
| | Venous Thrombosis | 1 | 2016 | 145 | 0.120 |
Why?
| | Risk Assessment | 7 | 2017 | 2987 | 0.110 |
Why?
| | Allografts | 1 | 2014 | 127 | 0.110 |
Why?
| | Prescription Drugs | 1 | 2015 | 116 | 0.110 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 182 | 0.110 |
Why?
| | Body Mass Index | 3 | 2016 | 1971 | 0.110 |
Why?
| | Joint Dislocations | 1 | 2014 | 56 | 0.110 |
Why?
| | Cartilage | 1 | 2015 | 182 | 0.110 |
Why?
| | Clinical Competence | 2 | 2017 | 912 | 0.110 |
Why?
| | Injury Severity Score | 3 | 2023 | 458 | 0.110 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 48 | 0.110 |
Why?
| | United States | 9 | 2022 | 12295 | 0.110 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 499 | 0.110 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 217 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 986 | 0.100 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 20 | 0.100 |
Why?
| | Bupivacaine | 1 | 2012 | 32 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1918 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 815 | 0.100 |
Why?
| | Knee Joint | 3 | 2022 | 325 | 0.100 |
Why?
| | Amides | 1 | 2012 | 88 | 0.100 |
Why?
| | Graft Survival | 1 | 2014 | 480 | 0.100 |
Why?
| | Bone and Bones | 1 | 2014 | 283 | 0.100 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1440 | 0.100 |
Why?
| | Treatment Failure | 3 | 2019 | 332 | 0.100 |
Why?
| | CpG Islands | 2 | 2021 | 118 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2015 | 497 | 0.100 |
Why?
| | Operative Time | 3 | 2017 | 109 | 0.100 |
Why?
| | Recovery of Function | 4 | 2016 | 577 | 0.100 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2800 | 0.090 |
Why?
| | Linear Models | 3 | 2021 | 776 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6417 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 129 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 783 | 0.090 |
Why?
| | North America | 1 | 2011 | 261 | 0.090 |
Why?
| | Sex Factors | 3 | 2021 | 1736 | 0.090 |
Why?
| | Trauma Centers | 2 | 2022 | 329 | 0.090 |
Why?
| | Mice | 2 | 2023 | 15052 | 0.080 |
Why?
| | Torque | 2 | 2021 | 65 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 2016 | 590 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 636 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2098 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 90 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1484 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 538 | 0.080 |
Why?
| | Facial Bones | 2 | 2001 | 30 | 0.080 |
Why?
| | Postoperative Care | 3 | 2015 | 222 | 0.080 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 135 | 0.070 |
Why?
| | Observer Variation | 2 | 2018 | 297 | 0.070 |
Why?
| | Regression Analysis | 2 | 2019 | 959 | 0.070 |
Why?
| | Bone Transplantation | 2 | 2019 | 99 | 0.070 |
Why?
| | Hemodilution | 2 | 1996 | 10 | 0.070 |
Why?
| | Equipment Design | 2 | 2019 | 517 | 0.060 |
Why?
| | Patient Care Team | 1 | 2010 | 521 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2019 | 5077 | 0.060 |
Why?
| | Prognosis | 3 | 2020 | 3339 | 0.060 |
Why?
| | Animals | 2 | 2023 | 32102 | 0.060 |
Why?
| | Middle Aged | 7 | 2022 | 26999 | 0.060 |
Why?
| | Knee Injuries | 2 | 2015 | 89 | 0.060 |
Why?
| | Pain Measurement | 2 | 2018 | 449 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 36 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 31 | 0.050 |
Why?
| | Colorado | 3 | 2018 | 4113 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 585 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 112 | 0.050 |
Why?
| | Pelvis | 1 | 2023 | 92 | 0.050 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 269 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 127 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 76 | 0.050 |
Why?
| | Anatomic Variation | 1 | 2021 | 5 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 66 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 65 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 58 | 0.050 |
Why?
| | Standard of Care | 1 | 2022 | 63 | 0.050 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 3 | 0.050 |
Why?
| | Chin | 1 | 2001 | 5 | 0.050 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 3 | 0.050 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 10 | 0.050 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 12 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 38 | 0.050 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 58 | 0.050 |
Why?
| | Malocclusion | 1 | 2001 | 23 | 0.050 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 21 | 0.050 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 11 | 0.050 |
Why?
| | Work | 1 | 2020 | 17 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2021 | 117 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 69 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2001 | 44 | 0.050 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 1829 | 0.050 |
Why?
| | Musculoskeletal System | 1 | 2021 | 44 | 0.050 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 162 | 0.050 |
Why?
| | Blood | 1 | 2001 | 97 | 0.050 |
Why?
| | Athletic Performance | 1 | 2020 | 42 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 46 | 0.040 |
Why?
| | Gait | 1 | 2022 | 249 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 268 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 201 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 413 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 22 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 99 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 47 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 152 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 477 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 44 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 746 | 0.040 |
Why?
| | Radiation Dosage | 1 | 2020 | 139 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 124 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 60 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 23 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 414 | 0.040 |
Why?
| | Eye Movements | 1 | 2019 | 53 | 0.040 |
Why?
| | Comorbidity | 2 | 2015 | 1473 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 585 | 0.040 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 79 | 0.040 |
Why?
| | Professional Competence | 1 | 2019 | 86 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 370 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 147 | 0.040 |
Why?
| | Random Allocation | 1 | 2019 | 337 | 0.040 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 71 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 89 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1103 | 0.040 |
Why?
| | Organ Size | 1 | 2018 | 434 | 0.040 |
Why?
| | Device Removal | 1 | 2018 | 128 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2018 | 220 | 0.040 |
Why?
| | Databases, Factual | 1 | 2021 | 1138 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 450 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 12 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 18 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 46 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 29 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 107 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 63 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 123 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 41 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 83 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 292 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1405 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 278 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 34 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 74 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 173 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 37 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 9 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 113 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 157 | 0.030 |
Why?
| | Skull | 1 | 1996 | 117 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 291 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 7 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 111 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 451 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 75 | 0.030 |
Why?
| | Edema | 1 | 1995 | 119 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 414 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2015 | 73 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 1765 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 222 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 341 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 44 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 337 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 69 | 0.030 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 40 | 0.030 |
Why?
| | Face | 1 | 1995 | 167 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 318 | 0.030 |
Why?
| | Self Report | 1 | 2016 | 698 | 0.030 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 45 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 448 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2385 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 2012 | 84 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 255 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 563 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1056 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 654 | 0.020 |
Why?
| | Communication | 1 | 2016 | 750 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 958 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 724 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1227 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 478 | 0.020 |
Why?
| | Lung | 1 | 2001 | 3672 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1870 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4665 | 0.020 |
Why?
| | Aged | 2 | 2022 | 19251 | 0.020 |
Why?
| | Critical Care | 1 | 2010 | 477 | 0.020 |
Why?
| | Length of Stay | 1 | 2010 | 958 | 0.020 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 64 | 0.020 |
Why?
| | Inflammation | 1 | 1996 | 2499 | 0.020 |
Why?
| | Orosomucoid | 1 | 1995 | 5 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 35 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 86 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 47 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 56 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 62 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 278 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 122 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 105 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 160 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 364 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 197 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|